Taurine ： 入眠困難
B エビデンス 少なくとも1件のランダム化試験がこれを支持しており、おおむね一貫した結果が得られています。Based on 9 studies (1 meta-analysis) with 32 total participants. Results are mixed across studies.
<\/script>\n`;
},
get iframeSnippet() {
const domain = 'sleepcited.com';
const params = 'ingredient\u003Dtaurine\u0026condition\u003Dsleep\u002Donset\u002Dlatency';
return ``;
},
get activeSnippet() {
return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet;
},
copySnippet() {
navigator.clipboard.writeText(this.activeSnippet).then(() => {
this.copied = true;
setTimeout(() => { this.copied = false; }, 2000);
});
}
}"
@keydown.escape.window="open = false"
@click.outside="open = false">
B
結論
Based on 9 studies (1 meta-analysis) with 32 total participants. Results are mixed across studies.
Key Study Findings
Controlled Clinical Trial
n=32
12 weeks
Open-label
Efficacy and associated neurotransmitters of digital cognitive behavior therapy for atopic dermatitis: A comparative effectiveness …
Dose: None
vs: Standard care alone
Outcome: Itch and insomnia improvement in atopic dermatitis
効果: None
0.0449 (itch), 0.0089 (insomni
対象集団: Patients with atopic dermatitis and mild-moderate negative emotions
Other
Energy drinks in Tamale: Understanding youth perceptions, consumption patterns, and related factors.
Dose: None
vs: None
Outcome: None
効果: None
p < .05
対象集団: Insomnia patients
Review
Commonly encountered symptoms and their management in patients with cirrhosis.
Dose: None
vs: None
Outcome: Pain outcomes
効果: None
None
対象集団: Insomnia patients
Observational Study
[Energy drink consumption patterns and its adverse effects on adolescent health.].
Dose: None
vs: None
Outcome: Energy drink consumption and adverse effects
効果: None
None
対象集団: Adolescents
Other
[Establishment of rat heart-kidney insomnia model consistent with traditional Chinese medicine syndrome and its serum …
Dose: None
vs: None
Outcome: rat model of cardiorenal insomnia from in vitro …
効果: None
None
対象集団: None
Review
Assessment and treatment of insomnia in adult patients with alcohol use disorders.
Dose: None
vs: None
Outcome: None
効果: None
None
対象集団: insomnia patients
Key Statistics
9
研究数
32
参加者数
↔
Mixed
B
グレード
Referenced Papers
Asian Pacific journal …
2025
6 件の引用
Energy drinks in Tamale: Understanding youth perceptions, consumption patterns, and related factors.
Other
PloS one
2024
5 件の引用
Frontiers in medicine
2024
4 件の引用
Revista espanola de …
2022
2 件の引用
Zhongguo Zhong yao …
2020
5 件の引用
Alcohol (Fayetteville, N.Y.)
2015
122 件の引用
British journal of …
2014
111 件の引用
Alcohol and alcoholism …
2011
40 件の引用
Journal of the …
2008
300 件の引用
Dosage & Usage
mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units
一般的な使用量
- sleep:
- 500-2,000 mg, 1 hour before bed
上限量： 3,000 mg/day considered safe in clinical studies
研究で検討された用量
| 用量 | 期間 | 効果 | N |
|---|---|---|---|
| None | 12 weeks | Positive | 32 |
| None | -- | Neutral | -- |
| None | -- | Neutral | -- |
| None | -- | Mixed | -- |
| None | -- | Mixed | -- |
| None | -- | Positive | -- |
| None | -- | Positive | -- |
| None | -- | Mixed | -- |
推奨摂取タイミング： 1 hour before bed
Safety & Side Effects
報告されている副作用
- ⚠ Generally well tolerated
- ⚠ Mild GI discomfort at high doses
- ⚠ Drowsiness (desired for sleep use)
既知の相互作用
- ● Lithium — taurine may alter lithium excretion
- ● Antihypertensives — may have additive blood pressure lowering effects
- ● CNS depressants — potential additive sedative effects
耐容上限摂取量： 3,000 mg/day considered safe in clinical studies
サプリメントの摂取を開始する前に、必ず医療専門家にご相談ください。
Frequently Asked Questions
Does Taurine help with 入眠困難?
Based on 9 studies with 32 participants, there is moderate evidence from clinical studies that Taurine may support 入眠困難 management. Our evidence grade is B (Good Evidence).
How much Taurine should I take for 入眠困難?
Studies have used various dosages. A commonly studied range is 500-2,000 mg, 1 hour before bed. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Taurine?
Reported side effects may include Generally well tolerated, Mild GI discomfort at high doses, Drowsiness (desired for sleep use). Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Taurine and 入眠困難?
We rate the evidence as Grade B (Good Evidence). This rating is based on 9 peer-reviewed studies with 32 total participants. The overall direction of effect is mixed.
Related Evidence
Taurine 他の症状・状態について
References
- [1] Wanying Zhai et al.. Asian Pac J Allergy Immunol. 2025. Efficacy and associated neurotransmitters of digital cognitive behavior therapy for atopic dermatitis: A comparative effectiveness research. doi:10.12932/AP-100223-1542 PubMed
- [2] Williams Kobik et al.. PLoS One. 2024. Energy drinks in Tamale: Understanding youth perceptions, consumption patterns, and related factors. doi:10.1371/journal.pone.0289391 PubMed
- [3] Cyriac Abby Philips. Front Med (Lausanne). 2024. Commonly encountered symptoms and their management in patients with cirrhosis. doi:10.3389/fmed.2024.1442525 PubMed
- [4] Paola Silva Maldonado et al.. Rev Esp Salud Publica. 2022. [Energy drink consumption patterns and its adverse effects on adolescent health.]. PubMed
- [5] Yu-Han Yang et al.. Zhongguo Zhong Yao Za Zhi. 2020. [Establishment of rat heart-kidney insomnia model consistent with traditional Chinese medicine syndrome and its serum metabolomics]. doi:10.19540/j.cnki.cjcmm.20190524.502 PubMed
- [6] Kirk J Brower. Alcohol. 2015. Assessment and treatment of insomnia in adult patients with alcohol use disorders. doi:10.1016/j.alcohol.2014.12.003 PubMed
- [7] Nicola J Kalk et al.. Br J Clin Pharmacol. 2014. The clinical pharmacology of acamprosate. doi:10.1111/bcp.12070 PubMed
- [8] Bhanu Prakash Kolla et al.. Alcohol Alcohol. 2011. Pharmacological treatment of insomnia in alcohol recovery: a systematic review. doi:10.1093/alcalc/agr073 PubMed
- [9] Kevin A Clauson et al.. J Am Pharm Assoc (2003). 2008. Safety issues associated with commercially available energy drinks. doi:10.1331/JAPhA.2008.07055 PubMed
FDAに関する免責事項: これらの記述は米国食品医薬品局（FDA）による評価を受けていません。本ウェブサイトの製品および情報は、疾病の診断、治療、治癒、または予防を目的としたものではありません。表示されているエビデンスグレードは、公開された査読済み研究の分析に基づいており、医療上の助言を構成するものではありません。サプリメントの摂取を開始する前に、必ず医療専門家にご相談ください。